Studies have shown that such diets elevate inflammatory markers like C-reactive protein (CRP) and interleukin-6 (IL-6), contributing to vascular damage, arterial stiffness, and worsening liver inflammation and fibrosis, thereby accelerating MASLD progression (40). This evidence concerns the gene IL6 and metabolic dysfunction-associated steatotic liver disease.